S&P 500   3,347.89 (-0.04%)
DOW   27,334.99 (-0.19%)
QQQ   273.98 (-0.24%)
AAPL   450.16 (-1.20%)
MSFT   214.50 (-0.86%)
FB   275.08 (+3.69%)
GOOGL   1,501.70 (-0.22%)
AMZN   3,216.00 (-0.28%)
NVDA   456.80 (+0.75%)
CGC   17.10 (-2.40%)
BABA   256.83 (-3.33%)
TSLA   1,483.04 (-0.44%)
MU   48.89 (+0.39%)
GE   6.28 (-0.79%)
AMD   85.82 (-1.03%)
T   29.62 (-0.74%)
F   6.86 (-1.01%)
ACB   10.23 (-0.78%)
GILD   69.15 (+0.49%)
NFLX   501.20 (-1.55%)
DIS   131.17 (+0.27%)
BAC   25.45 (-0.08%)
BA   170.79 (-0.82%)
S&P 500   3,347.89 (-0.04%)
DOW   27,334.99 (-0.19%)
QQQ   273.98 (-0.24%)
AAPL   450.16 (-1.20%)
MSFT   214.50 (-0.86%)
FB   275.08 (+3.69%)
GOOGL   1,501.70 (-0.22%)
AMZN   3,216.00 (-0.28%)
NVDA   456.80 (+0.75%)
CGC   17.10 (-2.40%)
BABA   256.83 (-3.33%)
TSLA   1,483.04 (-0.44%)
MU   48.89 (+0.39%)
GE   6.28 (-0.79%)
AMD   85.82 (-1.03%)
T   29.62 (-0.74%)
F   6.86 (-1.01%)
ACB   10.23 (-0.78%)
GILD   69.15 (+0.49%)
NFLX   501.20 (-1.55%)
DIS   131.17 (+0.27%)
BAC   25.45 (-0.08%)
BA   170.79 (-0.82%)
S&P 500   3,347.89 (-0.04%)
DOW   27,334.99 (-0.19%)
QQQ   273.98 (-0.24%)
AAPL   450.16 (-1.20%)
MSFT   214.50 (-0.86%)
FB   275.08 (+3.69%)
GOOGL   1,501.70 (-0.22%)
AMZN   3,216.00 (-0.28%)
NVDA   456.80 (+0.75%)
CGC   17.10 (-2.40%)
BABA   256.83 (-3.33%)
TSLA   1,483.04 (-0.44%)
MU   48.89 (+0.39%)
GE   6.28 (-0.79%)
AMD   85.82 (-1.03%)
T   29.62 (-0.74%)
F   6.86 (-1.01%)
ACB   10.23 (-0.78%)
GILD   69.15 (+0.49%)
NFLX   501.20 (-1.55%)
DIS   131.17 (+0.27%)
BAC   25.45 (-0.08%)
BA   170.79 (-0.82%)
S&P 500   3,347.89 (-0.04%)
DOW   27,334.99 (-0.19%)
QQQ   273.98 (-0.24%)
AAPL   450.16 (-1.20%)
MSFT   214.50 (-0.86%)
FB   275.08 (+3.69%)
GOOGL   1,501.70 (-0.22%)
AMZN   3,216.00 (-0.28%)
NVDA   456.80 (+0.75%)
CGC   17.10 (-2.40%)
BABA   256.83 (-3.33%)
TSLA   1,483.04 (-0.44%)
MU   48.89 (+0.39%)
GE   6.28 (-0.79%)
AMD   85.82 (-1.03%)
T   29.62 (-0.74%)
F   6.86 (-1.01%)
ACB   10.23 (-0.78%)
GILD   69.15 (+0.49%)
NFLX   501.20 (-1.55%)
DIS   131.17 (+0.27%)
BAC   25.45 (-0.08%)
BA   170.79 (-0.82%)
Log in

NASDAQ:DOXAmdocs Stock Price, Forecast & News

$61.87
-0.01 (-0.02 %)
(As of 08/7/2020 10:54 AM ET)
Add
Compare
Today's Range
$61.33
Now: $61.87▼
$61.88
50-Day Range
$58.21
MA: $60.35▼
$63.19
52-Week Range
$44.05
Now: $61.87▼
$77.29
Volume2,139 shs
Average Volume722,455 shs
Market Capitalization$8.34 billion
P/E Ratio17.23
Dividend Yield2.12%
Beta0.67
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions. It also provides managed, quality engineering, data and intelligence, cloud enablement, digital business operation, autonomous network service assurance, and advisory services. In addition, the company offers mobile financial services, which enable service providers and financial institutions to serve financially underserved customer segments; revenue guard services designed to detect and resolve revenue leakage, fraud, and cyber fraud; and the BriteBill, a multi-channel bill presentment platform focused on contextual and personalized customer engagements. Further, it provides advertising and media services for media publishers, TV networks, video streaming providers, advertising agencies, and service providers. The company was founded in 1988 and is headquartered in Chesterfield, Missouri.
Read More
Amdocs logo

Beat the Market (BTM) Rank™

Analyst Opinion: 2.3Community Rank: 2.9Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

2.28 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Custom computer programming services
Sub-IndustryIT Consulting & Other Services
SectorComputer and Technology
Current SymbolNASDAQ:DOX
Previous Symbol
CUSIPG0260210
CIK1062579
Webwww.amdocs.com
Phone1 314 212 7000

Debt

Debt-to-Equity Ratio0.06
Current Ratio1.25
Quick Ratio1.25

Price-To-Earnings

Trailing P/E Ratio17.23
Forward P/E Ratio15.16
P/E Growth1.79

Sales & Book Value

Annual Sales$4.09 billion
Price / Sales2.04
Cash Flow$5.69 per share
Price / Cash Flow10.87
Book Value$26.28 per share
Price / Book2.35

Profitability

EPS (Most Recent Fiscal Year)$4.07
Net Income$479.45 million
Net Margins11.71%
Return on Equity15.40%
Return on Assets9.95%

Miscellaneous

Employees24,516
Outstanding Shares134,770,000
Market Cap$8.34 billion
Next Earnings Date11/10/2020 (Estimated)
OptionableOptionable
$61.87
-0.01 (-0.02 %)
(As of 08/7/2020 10:54 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DOX News and Ratings via Email

Sign-up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Amdocs (NASDAQ:DOX) Frequently Asked Questions

How has Amdocs' stock been impacted by COVID-19 (Coronavirus)?

Amdocs' stock was trading at $61.42 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, DOX stock has increased by 0.7% and is now trading at $61.87.
View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Amdocs?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Amdocs.

When is Amdocs' next earnings date?

Amdocs is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Amdocs.

How were Amdocs' earnings last quarter?

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings data on Wednesday, August, 5th. The technology company reported $1.07 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.05 by $0.02. Amdocs had a return on equity of 15.40% and a net margin of 11.71%.
View Amdocs' earnings history.

How often does Amdocs pay dividends? What is the dividend yield for Amdocs?

Amdocs declared a quarterly dividend on Wednesday, August 5th. Investors of record on Wednesday, September 30th will be given a dividend of $0.327 per share on Friday, October 23rd. This represents a $1.31 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date is Tuesday, September 29th.
View Amdocs' dividend history.

What guidance has Amdocs issued on next quarter's earnings?

Amdocs updated its fourth quarter earnings guidance on Wednesday, August, 5th. The company provided earnings per share guidance of $1.16-1.22 for the period, compared to the Thomson Reuters consensus estimate of $1.16. The company issued revenue guidance of $1.015-1.055 billion, compared to the consensus revenue estimate of $1.03 billion.

What price target have analysts set for DOX?

5 analysts have issued 12 month price targets for Amdocs' stock. Their forecasts range from $72.00 to $76.00. On average, they expect Amdocs' share price to reach $74.40 in the next year. This suggests a possible upside of 20.3% from the stock's current price.
View analysts' price targets for Amdocs.

Has Amdocs been receiving favorable news coverage?

Media coverage about DOX stock has been trending positive this week, according to InfoTrie. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Amdocs earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term.
View the latest news about Amdocs.

Are investors shorting Amdocs?

Amdocs saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 2,590,000 shares, a drop of 9.1% from the July 15th total of 2,850,000 shares. Based on an average trading volume of 890,300 shares, the days-to-cover ratio is presently 2.9 days. Currently, 1.9% of the company's shares are sold short.
View Amdocs' Current Options Chain.

Who are some of Amdocs' key competitors?

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), EPAM Systems (EPAM), Leidos (LDOS), Gartner (IT), Booz Allen Hamilton (BAH), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Unisys (UIS), Forrester Research (FORR), The Hackett Group (HCKT) and Servicesource International (SREV).
View all competitors.

What other stocks do shareholders of Amdocs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AbbVie (ABBV), Comcast (CMCSA), AT&T (T), Walt Disney (DIS), Gilead Sciences (GILD), Home Depot (HD), Intel (INTC), Pfizer (PFE), Verizon Communications (VZ) and Cisco Systems (CSCO).

Who are Amdocs' key executives?

Amdocs' management team includes the following people:
  • Mr. Joshua Sheffer, Pres & CEO (Age 59)
  • Ms. Tamar Rapaport-Dagim, CFO & COO (Age 48)
  • Mr. Matthew E. Smith, Sec. & Head of Investor Relations (Age 47)
  • Mr. Gary Miles, Chief Marketing Officer
  • Darcy Antonellis, Head of Amdocs Media

What is Amdocs' stock symbol?

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Who are Amdocs' major shareholders?

Amdocs' stock is owned by a variety of institutional and retail investors. Top institutional investors include LSV Asset Management (3.80%), Robeco Institutional Asset Management B.V. (1.32%), Principal Financial Group Inc. (0.90%), First Trust Advisors LP (0.82%), Wedge Capital Management L L P NC (0.63%) and New York State Common Retirement Fund (0.54%).

Which institutional investors are selling Amdocs stock?

DOX stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Denali Advisors LLC, New York State Common Retirement Fund, Russell Investments Group Ltd., Robeco Institutional Asset Management B.V., WINTON GROUP Ltd, Raymond James & Associates, and Grandfield & Dodd LLC.

Which institutional investors are buying Amdocs stock?

DOX stock was acquired by a variety of institutional investors in the last quarter, including LSV Asset Management, Wedge Capital Management L L P NC, CWM LLC, Principal Financial Group Inc., UNIVEST FINANCIAL Corp, Exane Asset Management, Optimal Asset Management Inc., and Palouse Capital Management Inc..

How do I buy shares of Amdocs?

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Amdocs' stock price today?

One share of DOX stock can currently be purchased for approximately $61.87.

How big of a company is Amdocs?

Amdocs has a market capitalization of $8.34 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.

What is Amdocs' official website?

The official website for Amdocs is www.amdocs.com.

How can I contact Amdocs?

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]

This page was last updated on 8/7/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.